Course Content

What is Nanomedicine?

Nanomedicine is the application of Nanotechnology (materials with sizes in the nanometre range, i.e. 10-9 m) to promote innovation in Healthcare. Nanomedicine is a revolutionary interdisciplinary science, which combines knowledge from Pharmacy, Physics, Biology, Chemistry and Medicine to treat conditions and diseases of the human body at a molecular level. Nanomedicine has many applications, from drug therapy and diagnostics to individual cell repair, to artificial tissues and radiation therapy. Our NANOMED EMJMD is focusing on the drug delivery applications of Nanomedicine.

What is an EMJMD?

Erasmus Mundus Joint Master Degrees (EMJMDs) are highly integrated study programmes that are delivered by an international Consortium of Higher Education Institutions. They aim at fostering excellence, innovation, and internationalisation in Higher Education Institutions. The EMJMDs are supported by the EACEA (Education, Audiovisual and Culture Executive Agency) of the European Commission and are part of the Erasmus + programme.

You can participate to an EMJMD as a scholarship student or as a self-funded student. To learn more about the application procedure please click here.

Course content

The Nanomedicine for Drug Delivery, or in short NANOMED EMJMD, is a 22-months-long curriculum offering a high quality and multidisciplinary education in the emerging field of Nanomedicine. All courses will be taught in English.

The design of nanomedicines for drug delivery requires combining knowledge from Pharmacy, Biology, Chemistry, Medicine, Physics and Engineering which makes the NANOMED EMJMD a highly multidisciplinary Master’s degree. The frame of the EMJMD has thus been elaborated in order to be able to welcome students from different backgrounds who would show an interest in the field of Nanomedicine.

The NANOMED EMJMD provides both theoretical and practical knowledge for 3 semesters (Semesters 1, 2 and 3, 30 ECTS each) combined with a final traineeship (Semester 4, 30 ECTS).

Semester 1

Semester 1 (from September to January) will be dedicated to the “Introduction to pharmaceutical formulation: from classical forms to nanoparticles”. Training will either take place in Patras or in Paris and will concern the Basis of Pharmaceutical Technology, i.e. Biopharmacy aspects, formulation, production as well as the related controls. This first step provides the essential knowledge necessary to work in Pharmaceutical domains and to introduce innovative drug delivery systems as used in Nanomedicine.

At the very beginning of semester 1 (September), an introductory module will be offered to non-pharmacy students with a background in chemistry or biology. Considering that some specific knowledge in both domains is required to efficiently design and develop pharmaceutical forms and in particular Nanomedicines, basic courses on biology will be provided to Chemists and chemistry courses to Biologists.

Semester 2

Semester 2 courses (from February to March) will be held in Paris and will cover “Basic Nanomedicine and Advanced Biology”. The Basic Nanomedicine module is dedicated to the design of nanovectors for various administration routes as well as their subsequent characterization and evaluation (theoretical and practical courses). The Advanced Biology module concerns the study of biological and biotechnological medicinal products. A 3-months traineeship in one of the full partners’ laboratories (Angers, Paris, Patras or Pavia) will conclude this second semester (from April to June).

Each participating student will thus get the opportunity to share a common background in Drug Delivery and a serious introduction in Nanomedicine.

A two-weeks Summer School is organized at the end of semester 2 (July) in one of the four Universities of the NANOMED Consortium to give students the opportunity to benefit from high quality conferences of an Invited Professor. During the Summer School students will also be in charge of organizing and participating in a two-days-long workshop. This workshop will give NANOMED students from first and second year as well as local PhD students the opportunity to present their research projects (oral and poster communications will be organized).

Semester 3

Semester 3 (from September to December) will be dedicated to the Advanced Nanomedicine part of the curriculum. It corresponds to the specialization of students by choosing a training option according to their professional project.

In Angers, “Strategy of Nanomedicine Development for Clinical Application” is training professionals to manage innovative research project with skills in pharmaceutical development (Quality by Design) and non-clinical development of Nanomedicine.

In Pavia, the training will be dedicated to the “Production and Biotechnology applications of Nanomedicine” providing students with in-depth knowledge on different biotech applications, regulation and production.

Semester 4

During the final traineeship period (Semester 4, 6 months from January to June), students will apply this new knowledge to the successful achievement of research and development projects on Nanomedicine in either an academic team or selected private companies.

During the two-day-long workshop held in July, 2nd year students will defend their Master thesis in front of an international committee composed of international experts, NANOMED professors as well as traineeship supervisors.

Back to Top